Captisol
Lawrence, KS · United States
Specialization: Cyclodextrin solubility excipient
Key Differentiator
Captisol is found in 16 approved products and has been used in more than 500 clinical trials.
Core Services
Captisol (SBE-beta-cyclodextrin) supply; Solubility and stability enhancement; FDA Type IV and Type V DMF support; Formulation support (Captisol FAST program)
Capabilities
Market Intelligence
Part of Ligand, which acquired CyDex Pharmaceuticals in 2011. Produced under cGMP at validated sites in Loures, Portugal and Cork, Ireland.
Website
www.captisol.comSimilar Companies
Ashland (Pharma)
Wilmington, DE · Polymers & Specialty Ingredients
NYSE: ASH; broad polymer portfolio enabling modified-release and ODT formulations; critical role in amorphous solid dispersion technology for poorly soluble drugs
Avantor / J.T. Baker
Radnor, PA · High-Purity Chemicals & Excipients
NYSE: AVTR; $7.3B revenue; critical supplier of high-purity process chemicals to biopharma; opened advanced Dublin distribution center (Nov 2022)
Colorcon
Harleysville, PA · Film Coatings & Colorants
World leader in film coating systems; signed $740M 10-year deal with Lotte Fine Chemical for pharma cellulose (Oct 2024); global supply + application labs network
DFE Pharma
Toronto region, ON · Lactose & Inhalation Excipients
World leader in lactose-based excipients; Canadian distribution serving growing domestic pharma manufacturing sector
Need help finding the right outsourcing partner?
Try AI NavigatorCompany information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.